Trial Outcomes & Findings for Allergens in Inner-City Schools and Childhood Asthma (NCT NCT01756391)

Results Overview

Largest value among the following: Number of days with wheezing, tightness in the chest, or cough Number of nights with disturbed sleep as a result of asthma Number of days on which the child had to slow down or discontinue play activities because of asthma

Recruitment status

COMPLETED

Target enrollment

351 participants

Primary outcome timeframe

14 days

Results posted on

2014-12-08

Participant Flow

Participant milestones

Participant milestones
Measure	Observational Cohort students with asthma grades K-8 after the spring screening attending schools where permission for sampling obtained
Overall Study STARTED	351
Overall Study COMPLETED	319
Overall Study NOT COMPLETED	32

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Allergens in Inner-City Schools and Childhood Asthma

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Observational Cohort n=351 Participants students with asthma grades K-8 after the spring screening attending schools where permission for sampling obtained
Age, Continuous	7.9 years n=5 Participants
Sex: Female, Male Female	169 Participants n=5 Participants
Sex: Female, Male Male	182 Participants n=5 Participants
Region of Enrollment United States	351 participants n=5 Participants

PRIMARY outcome

Timeframe: 14 days

Population: Those with appropriate follow up and school/home allergen exposure data and allergy sensitization data

Largest value among the following: Number of days with wheezing, tightness in the chest, or cough Number of nights with disturbed sleep as a result of asthma Number of days on which the child had to slow down or discontinue play activities because of asthma

Outcome measures

Outcome measures
Measure	Observational Cohort n=284 Participants students with asthma grades K-8 after the spring screening attending schools where permission for sampling obtained
Maximum Symptom Days/14 Days	2.7 days Standard Deviation 4

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

Adverse Events

Observational Cohort

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Wanda Phipatanakul

Boston Children's Hospital

Phone: 617-355-6117

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place